Reuters logo
BRIEF-Galenica: Vifor Pharma expands ESA product portfolio
May 24, 2016 / 4:55 AM / 2 years ago

BRIEF-Galenica: Vifor Pharma expands ESA product portfolio

May 24 (Reuters) - Galenica AG :

* Vifor Pharma, a company of the Galenica group, expands ESA product portfolio with rights to commercialise Pfizer'S proposed epoetin alfa biosimilar, Retacrit, in the US dialysis market Source text - bit.ly/1TIrOWp Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below